Form 4: Hims & Hers CFO Okupe Reports Stock Transactions
Insider Transaction Report
Hims & Hers Health, Inc. CFO Oluyemi Okupe reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations on December 15, 2025.
Summary
- Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., reported transactions on December 15, 2025.
- Acquired 105,201 shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
- Disposed of 58,010 shares of Class A Common Stock at a price of $36.25 per share to cover tax withholding obligations related to the RSU vesting.
- Following these transactions, direct beneficial ownership of Class A Common Stock is 117,423 shares.
- Indirect beneficial ownership of Class A Common Stock is 7,853 shares, held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.
- Derivative securities (RSUs) totaling 105,201 units vested on the transaction date.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions related to executive compensation (RSU vesting and tax-related sales), which are expected and do not indicate a significant positive or negative shift in company performance or outlook.
Positives
- The vesting of 105,201 Restricted Stock Units (RSUs) indicates continued executive compensation and retention of the Chief Financial Officer.
- The acquisition of shares through RSU vesting demonstrates the executive's ongoing equity stake in the company.
Negatives
- The disposal of 58,010 shares, although for tax withholding, reduces the executive's direct beneficial ownership.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- 7,853 shares of Class A Common Stock are indirectly held by the Oluyemi Okupe Separate Property Trust dtd 9-1-2021.
Stakeholder Impact
- Shareholders: Minimal impact as these are routine, pre-scheduled compensation events for a key executive, reflecting standard corporate governance practices for executive incentives.
- Management: The CFO's compensation structure includes equity incentives, aligning interests with shareholders.
Next Steps
- Remaining Restricted Stock Units (RSUs) will continue to vest in substantially equal quarterly installments on March 15, June 15, September 15, and December 15, subject to service-based requirements.
Key Dates
| Date | Description |
|---|---|
| 2021-09-01 | Date of Oluyemi Okupe Separate Property Trust. |
| 2023-03-15 | First vesting date for a tranche of RSUs (25% of initial grant). |
| 2023-06-15 | First vesting date for a tranche of RSUs. |
| 2024-06-15 | First vesting date for a tranche of RSUs. |
| 2025-06-15 | First vesting date for a tranche of RSUs. |
| 2025-12-15 | Date of RSU vesting and tax-related share disposition. |
| 2025-12-16 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThe Form 4 filing details a routine vesting of restricted stock units and a subsequent tax-related sale by the CFO. These transactions are part of standard executive compensation and do not indicate a change in the company's fundamentals or the executive's long-term outlook on the stock. Therefore, it does not warrant a change in investment recommendation based solely on this filing.
Keywords
Hims & Hers, HIMS, SEC Form 4, insider trading, stock transactions, CFO, restricted stock units, RSU vesting, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.